Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Gastroparesis Clinical Trials

A listing of Gastroparesis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (33) clinical trials

A research study is evaluating an investigational drug for Diabetic Gastroparesis.

Phase N/A

Diabetic Gastroparesis creates feelings of bloating, nausea, vomiting and pain.

Phase N/A

0099 : A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis.

Phase N/A

A clinical trial is being conducted to assess the safety and efficacy of a treatment for patients with diabetic and non-diabetic gastroparesis.

Phase N/A

Gastroparesis creates feelings of bloating, nausea, vomiting and pain. Wake Research Associates is enrolling volunteers with idiopathic or diabetic gastroparesis in a study testing an investigational medication.

Phase N/A

Do you suffer from gastroparesis? You may qualify for a clinical research study. Gastroparesis creates feelings of bloating, nausea, vomiting and pain. ClinSearch is enrolling volunteers with idiopathic or diabetic gastroparesis in a study testing an investigational medication.

Phase N/A

Gastroparesis creates feelings of bloating, nausea, vomiting and pain. ClinSearch is enrolling volunteers in a study testing for individuals with diabetic or idiopathic gastroparesis.

Phase N/A

Prucalopride Versus Placebo in Gastroparesis

The incidence of gastroparesis has been increasing among Canadians. Symptoms of discomfort include early satiety, stomach pain, nausea and vomiting. In addition, because gastroparesis slows digestion, it can lead to malnutrition and make controlling blood sugar even more challenging for diabetics. Mild cases of gastroparesis can be helped with dietary ...

Phase

Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People

Lixisenatide is a drug that has been shown to reduce postprandial glycaemia in people with type 2 diabetes and is now approved for use in Australia. Although slowing of gastric emptying is likely to be the dominant mechanism by which lixisenatide reduces postprandial glycaemia after a meal, the effects of ...

Phase

RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease

This is a phase Ib study with the primary objectives of determining the safety and tolerability as well as pharmacokinetics after single ascending doses (SAD) and multiple ascending doses (MAD) of RQ10 in Parkinson's disease patients. A secondary objective will be to assess the impact of single doses of RQ10 ...

Phase